Anne-Marie Malfait to Protease Inhibitors
This is a "connection" page, showing publications Anne-Marie Malfait has written about Protease Inhibitors.
Connection Strength
0.607
-
Genetically Engineered Mouse Models Reveal the Importance of Proteases as Osteoarthritis Drug Targets. Curr Rheumatol Rep. 2013 Aug; 15(8):350.
Score: 0.443
-
Transport and equilibrium uptake of a peptide inhibitor of PACE4 into articular cartilage is dominated by electrostatic interactions. Arch Biochem Biophys. 2010 Jul; 499(1-2):32-9.
Score: 0.088
-
Will the real aggrecanase(s) step up: evaluating the criteria that define aggrecanase activity in osteoarthritis. Curr Pharm Biotechnol. 2008 Feb; 9(1):16-23.
Score: 0.076